---
audienceLevel: patient
cancerTypes:
- breast
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Letrozole - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/letrozole
version: v1
---

# Letrozole - NCI

# Letrozole

Placeholder slot

(LEH-truh-zole)

Letrozole works by temporarily blocking the activity of an enzyme called aromatase, which the body uses to make estrogen in the ovaries and other tissues. Blocking aromatase decreases the amount of estrogen produced by the body and may stop the growth of cancer cells that need estrogen to grow. Letrozole is a type of hormone therapy called an aromatase inhibitor.

US Brand Name(s)

Femara

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=LETROZOLE&pagesize=20&page=1&audience=consumer)

## Use in Cancer

Letrozole is approved to be used alone or with other drugs to treat:

- **[breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English)** in [postmenopausal](/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=English) women who have any of the following types of breast cancer:
- [early-stage](/Common/PopUps/popDefinition.aspx?id=446564&version=Patient&language=English), [hormone receptorâ€“positive](/Common/PopUps/popDefinition.aspx?id=788029&version=Patient&language=English) (HR+) breast cancer that has been treated
- early-stage breast cancer that has been treated with [tamoxifen citrate](/Common/PopUps/popDefinition.aspx?id=509341&version=Patient&language=English) for at least 5 years
- as the first treatment for breast cancer that is [locally advanced](/Common/PopUps/popDefinition.aspx?id=45955&version=Patient&language=English) or has metastasized (spread to other parts of the body) and is HR+
- as the first treatment for breast cancer that is locally advanced or has metastasized and it is not known whether the cancer is HR+ or [hormone receptor negative](/Common/PopUps/popDefinition.aspx?id=788033&version=Patient&language=English) (HR-)
- as the second treatment for breast cancer that has gotten worse after [antiestrogen](/Common/PopUps/popDefinition.aspx?id=44813&version=Patient&language=English) therapy

Letrozole is also available in a combination pack with [ribociclib succinate](/Common/PopUps/popDefinition.aspx?id=787678&version=Patient&language=English). Ribociclib succinate and letrozole may work better together than when either is given alone. For more information that may apply to this combination pack, see the Drug Information Summary for [Ribociclib Succinate and Letrozole](/about-cancer/treatment/drugs/ribociclib-succinate-and-letrozole).

Letrozole is also being studied in the treatment of other types of cancer.

## More About Letrozole

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/42086) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Letrozole](https://medlineplus.gov/druginfo/meds/a698004.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancers](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Combo of Ribociclib, Letrozole Improves Survival in Advanced Breast Cancer](https://www.cancer.gov/news-events/cancer-currents-blog/2021/ribociclib-improves-metastatic-breast-cancer-survival)

[Hormone Therapy for Breast Cancer](https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Letrozole](https://www.cancer.gov/research/participate/clinical-trials/intervention/C1527) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
